arrow
S

Stefan Bonn

german center for neurodegenerative diseases
H指数:41
被引数:7,421

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunological maladaptation preceding spontaneous preterm birth in human pregnancies

人类妊娠中自发早产前的免疫不良适应

2026-07-270
OA
Mega-scale single-cell profiling reveals novel biomarkers associated with acute GvHD after allogeneic hematopoietic stem cell transplantation

大规模单细胞图谱分析揭示了与异基因造血干细胞移植后急性移植物抗宿主病相关的新的生物标志物

2025-12-010
OAAI
Multiomic approach to study the immunologic profile preceding preterm birth

多组学方法研究早产前的免疫学特征

2025-11-140
PRE
BioContextAI is a community hub for agentic biomedical systems

BioContextAI是代理生物医学系统的社区中心

2025-11-060
PRE
Spatiotemporal interaction of immune and renal cells controls glomerular crescent formation in autoimmune kidney disease

免疫细胞和肾细胞的时空相互作用调控自身免疫性肾脏疾病中的肾小球新月体形成

2025-09-300
OAAI
Metabolite-enhanced normothermic machine perfusion improves kidney transplant viability

代谢物增强型常温机器灌注可提高肾脏移植的存活能力

2025-09-230
PRE
A stronger type I interferon signature distinguishes ANCA-associated vasculitis phenotypes and predicts kidney prognosis

更强的I型干扰素特征可区分抗中性粒细胞胞浆抗体相关性血管炎表型并预测肾脏预后

2025-09-100
PRE
Pathology-oriented multiplexing enables integrative disease mapping

以病理学为导向的多路复用可实现综合疾病映射

Nature
IF48.5
2025-07-180
OA
Type I interferon drives T cell cytotoxicity by upregulation of interferon regulatory factor 7 in autoimmune kidney diseases in mice

I型干扰素通过上调干扰素调节因子7,在自身免疫性肾脏疾病的小鼠中驱动T细胞细胞毒性。

2025-05-200
OA
Intermittent fasting boosts sexual behavior by limiting the central availability of tryptophan and serotonin

间歇性禁食通过限制色氨酸和5-羟色胺在中央的可用性来增强性行为。

2025-05-010
OAAI
Optimized protocol for the multiomics processing of cryopreserved human kidney tissue
2024-11-010
PRE
Immune profiling-based targeting of pathogenic T cells with ustekinumab in ANCA-associated glomerulonephritis
2024-09-191
OA
Targeting T cell plasticity in kidney and gut inflammation by pooled single-cell CRISPR screening
2024-06-140
PRE
Multiomic ALS signatures highlight subclusters and sex differences suggesting the MAPK pathway as therapeutic target
2024-06-072
OAAI